Photoactivatable Platinum-Based Anticancer Drugs: Mode of Photoactivation and Mechanism of Action
Platinum-based anticancer drugs are a class of widely used agents in clinical cancer treatment. However, their efficacy was greatly limited by their severe side effects and the arising drug resistance. The selective activation of inert platinum-based drugs in the tumor site by light irradiation is a...
Main Authors: | Ziwen Dai, Zhigang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/21/5167 |
Similar Items
-
Ligand Evolution in the Photoactivatable Platinum(IV) Anticancer Prodrugs
by: Jingjing Huang, et al.
Published: (2022-06-01) -
Photoactivable Ruthenium-Based Coordination Polymer Nanoparticles for Light-Induced Chemotherapy
by: Junda Zhang, et al.
Published: (2021-11-01) -
Recent Advances in Light-Controlled Activation of Pt(IV) Prodrugs
by: Daniil Spector, et al.
Published: (2022-11-01) -
A Ru(II)-Strained Complex with 2,9-Diphenyl-1,10-phenanthroline Ligand Induces Selective Photoactivatable Chemotherapeutic Activity on Human Alveolar Carcinoma Cells via Apoptosis
by: Najwa Mansour, et al.
Published: (2023-12-01) -
Design, Synthesis, and In Vitro Evaluation of the Photoactivatable Prodrug of the PARP Inhibitor Talazoparib
by: Jiaguo Li, et al.
Published: (2020-01-01)